For years, those of us working in nutrition and healthcare have made the case that food is medicine. We pointed to small but promising studies, patient stories, and pilot programs that hinted at what was possible when nutrition was treated as part of clinical care rather than an afterthought.

Today, that argument has fundamentally changed. The question is no longer whether food is medicine. The evidence is now too strong to ignore. The real question is: what are we going to do about it?

A growing body of research from institutions like Tufts University, Kaiser Permanente, and the MANNA Institute has made one thing clear: medically tailored meals and nutrition interventions are not just compassionate, they are clinically effective and cost efficient. Studies consistently show reductions in hospitalizations, fewer emergency department visits, and meaningful improvements in chronic disease outcomes such as diabetes and heart disease. The economic case is becoming equally compelling. New research from The Rockefeller Foundation found that broad adoption of Food Is Medicine interventions could generate as much as $45 billion in annual net savings for states and taxpayers, while improving health outcomes and reducing avoidable healthcare utilization. This is no longer a promising concept; it is an evidence-based strategy with the potential to transform both patient care and healthcare spending.

This is not theoretical. At MANNA, we see these outcomes play out every day.

We serve individuals living with serious illnesses. People managing cancer, renal disease, heart failure, HIV/AIDS, and more, who are often discharged from the hospital with complex dietary needs but no realistic way to meet them. When medically tailored meals are introduced, paired with nutrition counseling from registered dietitians, we see stabilization. We see fewer readmissions. We see people regain strength, adhere to treatment plans, and in many cases, avoid costly complications altogether.

The clinical case is clear. And yet, access remains limited.

Despite the strength of the evidence, medically tailored nutrition is still not a standard, reimbursable benefit across most of our healthcare system. Coverage varies widely depending on geography, payer, and program design. Medicare Advantage plans have made some progress through supplemental benefits, and Medicaid waivers in several states are beginning to incorporate nutrition supports under health-related social needs. But these efforts remain fragmented and inconsistent.

This gap between evidence and access is where the system is currently failing patients.

Part of the challenge is that as “food is medicine” gains national attention, the term itself is being stretched. Not all meal programs are created equal. Medically tailored meals are not simply healthy food deliveries; they are prescribed interventions, designed by registered dietitians, tailored to specific diagnoses, and integrated into a patient’s care plan.

As more commercial players enter the space, there is a risk that scale will outpace fidelity. Without clear standards, we risk diluting the very outcomes that have made this field credible.

If we are serious about improving health and reducing costs, we must be equally serious about maintaining clinical integrity.

That means prioritizing models that are evidence-based, dietitian-led, and accountable for outcomes. It means investing in providers who can deliver not just meals, but medically appropriate care. And it means aligning reimbursement with interventions that have been proven to work.

We are at an inflection point. Policymakers on both sides of the aisle are expressing interest. Federal agencies are increasingly incorporating food is medicine into their frameworks. The healthcare industry is actively searching for solutions to rising costs and poor chronic disease outcomes.

The opportunity is here. What is needed now is the will to act at scale, with intention, and with a commitment to quality.

Because the evidence is no longer the barrier. It’s the blueprint.